Patent classifications
C07C271/22
Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
A composition, in the form of an aqueous solution, including insulin in hexameric form, at least one substituted anionic compound of non-saccharide structure and at least one polyanionic compound other than the substituted anionic compound.
Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
A composition, in the form of an aqueous solution, including insulin in hexameric form, at least one substituted anionic compound of non-saccharide structure and at least one polyanionic compound other than the substituted anionic compound.
Process for the preparation of N-((1R,2S,5R)-5-(<i>tert</i>-butylamino)-2-((S)-3-(7-<i>tert</i>-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrroldin-1-yl)cyclohexyl)acetamide
- Burcu Selin Aytar ,
- Alina Borovika ,
- Collin Chan ,
- Joerg Deerberg ,
- Nathan R. Domagalski ,
- Martin D. Eastgate ,
- Yu Fan ,
- Michael David Bengt Fenster ,
- Robert V. Forest ,
- Francisco Gonzalez-Bobes ,
- Rebecca A. Green ,
- Matthew R. Hickey ,
- Nathaniel David Kopp ,
- Thomas E. La Cruz ,
- Kathleen Lauser ,
- Hong Geun Lee ,
- David K. Leahy ,
- Helen Y. Luo ,
- Thomas M. Razler ,
- Scott A. Savage ,
- Chris Sfouggatakis ,
- Maxime C. D. Soumeillant ,
- Serge Zaretsky ,
- Bin Zheng ,
- Ye Zhu
The invention generally relates to an improved process for the preparation of N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, ##STR00001## as well as novel intermediates employed in the process, which may be useful for the treatment of cancer.
Process for the preparation of N-((1R,2S,5R)-5-(<i>tert</i>-butylamino)-2-((S)-3-(7-<i>tert</i>-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrroldin-1-yl)cyclohexyl)acetamide
- Burcu Selin Aytar ,
- Alina Borovika ,
- Collin Chan ,
- Joerg Deerberg ,
- Nathan R. Domagalski ,
- Martin D. Eastgate ,
- Yu Fan ,
- Michael David Bengt Fenster ,
- Robert V. Forest ,
- Francisco Gonzalez-Bobes ,
- Rebecca A. Green ,
- Matthew R. Hickey ,
- Nathaniel David Kopp ,
- Thomas E. La Cruz ,
- Kathleen Lauser ,
- Hong Geun Lee ,
- David K. Leahy ,
- Helen Y. Luo ,
- Thomas M. Razler ,
- Scott A. Savage ,
- Chris Sfouggatakis ,
- Maxime C. D. Soumeillant ,
- Serge Zaretsky ,
- Bin Zheng ,
- Ye Zhu
The invention generally relates to an improved process for the preparation of N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, ##STR00001## as well as novel intermediates employed in the process, which may be useful for the treatment of cancer.
Reagents and methods for esterification
Methods and reagents for esterification of biological molecules including proteins, polypeptides and peptides. Diazo compounds of formula I: ##STR00001##
where R is hydrogen, an alkyl, an alkenyl or an alkynyl, R.sub.A represents 1-5 substituents on the indicated phenyl ring and R.sub.M is an organic group, which includes a label, a cell penetrating group, a cell targeting group, or a reactive group or latent reactive group for reaction to bond to a label, a cell penetrating group, or a cell targeting group, among other organic groups are useful for esterification of biological molecules. Also provided are diazo compounds which are bifunctional and trifunctional coupling reagents as well as reagents for the synthesis of compounds of formula I.
Reagents and methods for esterification
Methods and reagents for esterification of biological molecules including proteins, polypeptides and peptides. Diazo compounds of formula I: ##STR00001##
where R is hydrogen, an alkyl, an alkenyl or an alkynyl, R.sub.A represents 1-5 substituents on the indicated phenyl ring and R.sub.M is an organic group, which includes a label, a cell penetrating group, a cell targeting group, or a reactive group or latent reactive group for reaction to bond to a label, a cell penetrating group, or a cell targeting group, among other organic groups are useful for esterification of biological molecules. Also provided are diazo compounds which are bifunctional and trifunctional coupling reagents as well as reagents for the synthesis of compounds of formula I.
Methods of producing cancer treating compounds
Provided herein are methods of making the compound of Formula I: ##STR00001##
and certain intermediates involved in such process.
Methods of producing cancer treating compounds
Provided herein are methods of making the compound of Formula I: ##STR00001##
and certain intermediates involved in such process.
Methods of producing cancer treating compounds
Provided herein are methods of making the compound of Formula I: ##STR00001##
and certain intermediates involved in such process.
PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY
This disclosure relates to picolinamides of Formula I and their use as fungicides.
##STR00001##